Lilly ICOS LLC Sustainability Profile
Lilly ICOS LLC, a prominent player in the pharmaceutical industry, is headquartered in the United States and operates extensively across North America and Europe. Founded in 2002 as a joint venture between Eli Lilly and Company and ICOS Corporation, the company has made significant strides in the development of innovative treatments for erectile dysfunction and other urological conditions. Lilly ICOS is best known for its flagship product, Cialis, which offers a unique once-daily dosing option, setting it apart from competitors. The company has established a strong market position, recognised for its commitment to research and development, and has achieved notable milestones in expanding access to its therapies. With a focus on improving patient outcomes, Lilly ICOS continues to lead in the urology sector, driving advancements that enhance quality of life for men worldwide.
DitchCarbon Score
How does Lilly ICOS LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Lilly ICOS LLC's score of 24 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Lilly ICOS LLC, headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Eli Lilly and Company, which cascades its climate commitments and performance data. Eli Lilly and Company, the parent organisation, has set ambitious climate targets, including commitments to reduce greenhouse gas emissions across its operations. However, specific reduction targets or achievements for Lilly ICOS LLC have not been disclosed. As part of its corporate family, Lilly ICOS LLC aligns with the sustainability initiatives of Eli Lilly and Company, which participates in the CDP and RE100 initiatives, aiming for significant reductions in carbon emissions and a transition to renewable energy sources. While Lilly ICOS LLC does not have its own emissions data or specific reduction targets, it is positioned within a framework of broader climate commitments established by its parent company, reflecting a commitment to sustainability and climate action in the pharmaceutical industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 502,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 1,310,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 200,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | - |
How Carbon Intensive is Lilly ICOS LLC's Industry?
How Carbon Intensive is Lilly ICOS LLC's Location?
Lilly ICOS LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Lilly ICOS LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
